Skip to main content
UniHealth

Doctor search

Michael John Conte, PA

Physician Assistant · Palo Alto

NPI 1194731034

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Michael John Conte’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A55048 · Current

Licensed to practise in California · since 1995 · expires 2027-10-31 · University of Texas Medical School at San Antonio.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$32,867

Medicare paid this office $32,867 for 92 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)74$25,760$131
Long return visit (40+ min)34$4,063$97
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or22$1,134$25

Who their Medicare patients are

92 Original Medicare patients in 2024. Average age 75 · Women 40% · Health risk score 1.81. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 57% · Chronic kidney disease 25% · Cancer 18% · Coronary heart disease 17% · Diabetes 16% · Atrial fibrillation 16%.

The office billed $219,699, Medicare allowed $46,054 and paid $32,867; for 313 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202492313751.81$219,699$32,867
202383265741.75$180,186$23,733
2022112248742.15$176,433$21,744
2021109178751.84$102,445$14,997
20204772752.71$29,289$4,542
20194768713.11$50,059$3,987
20182630733.19$15,164$1,837
2017207415752.05$50,024$27,529
2016155393741.81$48,536$26,201
2015142321731.85$41,728$23,310
20141275,161741.66$309,802$194,981
2013972,478741.94$261,506$188,151

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)79$21,372$103
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or15$1,159$25

2022: 2 services

Original Medicare services billed in 2022
Long return visit (40+ min)90$17,752$106
Return visit (30+ min)43$3,244$52

2021: 2 services

Original Medicare services billed in 2021
Return visit (30+ min)70$7,431$74
Long return visit (40+ min)48$7,190$111

2020: 2 services

Original Medicare services billed in 2020
Long return visit (40+ min)19$2,087$91
Return visit (30+ min)22$1,998$57

2019: 2 services

Original Medicare services billed in 2019
Long return visit (40+ min)24$2,498$86
Return visit (30+ min)13$879$59

2018: 1 service

Original Medicare services billed in 2018
Return visit (30+ min)17$1,021$57

2017: 1 service

Original Medicare services billed in 2017
Return visit (30+ min)200$26,508$66

2016: 1 service

Original Medicare services billed in 2016
Return visit (30+ min)145$24,771$66

2015: 2 services

Original Medicare services billed in 2015
Return visit (30+ min)116$15,743$68
Long return visit (40+ min)60$7,085$91

2014: 2 services

Original Medicare services billed in 2014
Long return visit (40+ min)94$18,070$86
Return visit (30+ min)73$9,705$66

2013: 2 services

Original Medicare services billed in 2013
Long return visit (40+ min)88$24,879$90
Return visit (30+ min)36$4,539$64

Drugs they prescribed that Part D paid

$1,423,200

Pharmacies billed $1,423,200 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 211) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.

0 generic and 129 brand-name prescriptions · $1,423,200 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Venclexta47$515,264$10,963
Calquence28$395,560$14,127
Brukinsa28$290,723$10,383
Acyclovir37$766$21
Allopurinol21$237$11

Year by year

Part D prescribing by year
2024211470% (0)61%$1,423,200
202321351None68%$1,878,102
20223861063% (11)57%$2,346,366
20216751872% (13)53%$3,677,337
20207271936% (43)50%$3,142,444
20192611007% (17)49%$907,413
201818869None54%$868,416
2017393664% (16)61%$1,877,179
201634353None62%$1,260,449
201525642None44%$452,267
2014289444% (12)31%$432,728
201314038None13%$42,539

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 5 drugs

Part D drugs prescribed in 2023
Calquence42$649,598$15,467
Venclexta41$521,761$12,726
Imbruvica21$342,159$16,293
Acyclovir11$274$25
Allopurinol21$236$11

2022: 10 drugs

Part D drugs prescribed in 2022
Venclexta58$529,774$9,134
Jakafi29$480,381$16,565
Calquence26$393,795$15,146
Imbruvica25$358,285$14,331
Tasigna11$208,806$18,982
Pegasys13$57,371$4,413
Eliquis18$14,752$820
Acyclovir35$698$20
Hydroxyurea12$384$32
Allopurinol17$234$14

2021: 17 drugs

Part D drugs prescribed in 2021
Imbruvica78$1,075,753$13,792
Jakafi50$722,630$14,453
Venclexta70$482,092$6,887
Rydapt11$434,939$39,540
Calquence13$194,406$14,954
Pegasys13$54,137$4,164
Eliquis26$20,076$772
Xarelto20$13,336$667
Imatinib Mesylate15$11,146$743
Enoxaparin12$2,298$192
Acyclovir66$1,905$29
Hydroxyurea27$1,786$66
Allopurinol16$218$14
Dexamethasone16$193$12
Pantoprazole12$180$15
Sulfamethoxazole-Trimethoprim18$130$7
Prednisone22$123$6

2020: 15 drugs

Part D drugs prescribed in 2020
Imbruvica77$1,092,610$14,190
Jakafi43$529,181$12,307
Venclexta66$446,867$6,771
Procrit14$51,393$3,671
Eliquis49$29,557$603
Xarelto34$22,146$651
Imatinib Mesylate14$10,059$719
Hydroxyurea32$2,030$63
Acyclovir103$1,773$17
Dexamethasone23$431$19
Pantoprazole11$204$19
Allopurinol16$203$13
Prednisone17$82$5
Lorazepam12$80$7
Sulfamethoxazole-Trimethoprim12$65$5

2019: 6 drugs

Part D drugs prescribed in 2019
Venclexta30$217,006$7,234
Jakafi14$199,717$14,265
Eliquis27$14,543$539
Hydroxyurea21$773$37
Acyclovir25$362$14
Allopurinol11$114$10

2018: 4 drugs

Part D drugs prescribed in 2018
Imbruvica69$611,610$8,864
Sprycel11$159,727$14,521
Valacyclovir28$1,378$49
Acyclovir20$422$21

2017: 5 drugs

Part D drugs prescribed in 2017
Imbruvica212$1,667,262$7,864
Venclexta17$166,537$9,796
Valacyclovir46$2,482$54
Acyclovir24$782$33
Sulfamethoxazole-Trimethoprim11$51$5

2016: 5 drugs

Part D drugs prescribed in 2016
Imbruvica166$1,138,724$6,860
Valacyclovir16$711$44
Acyclovir20$475$24
Prednisone19$232$12
Sulfamethoxazole-Trimethoprim19$83$4

2015: 3 drugs

Part D drugs prescribed in 2015
Imbruvica73$410,207$5,619
Valacyclovir37$1,631$44
Allopurinol13$247$19

2014: 4 drugs

Part D drugs prescribed in 2014
Imbruvica59$394,110$6,680
Valacyclovir45$2,957$66
Sulfamethoxazole-Trimethoprim15$107$7
Levofloxacin13$97$7

2013: 3 drugs

Part D drugs prescribed in 2013
Acyclovir18$498$28
Prednisone21$158$8
Sulfamethoxazole-Trimethoprim18$140$8

Money from drug and device companies

$81 in 2025

Industry payments by year
202523None$81
2024712$3,225$3,745
2023611$1,000$1,686
202233$1,018$1,031
202124$1,653$1,780

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Rigel PharmaceuticalsTavalisse$57
2 payments
  • Meals for Tavalisse · 2025-04-02 · $32
  • Meals for Tavalisse · 2025-01-22 · $25
Secura BioCopiktra$25
1 payment
  • Meals for Copiktra · 2025-06-19 · $25
See all 3 published payments
Every published payment
Secura BioMeals · 2025-06-19Copiktra$25
Rigel PharmaceuticalsMeals · 2025-04-02Tavalisse$32
Rigel PharmaceuticalsMeals · 2025-01-22Tavalisse$25
See earlier years (2024, 2023, 2022, 2021)

2024: $3,745

Payments by company in 2024
AbbvieVenclexta$3,468
6 payments
  • Paid to speak or teach for Venclexta · 2024-12-31 · $750
  • Paid to speak or teach for Venclexta · 2024-12-24 · $1,250
  • Meals for Venclexta · 2024-12-03 · $114
  • Meals for Venclexta · 2024-11-19 · $125
  • Meals for Imbruvica · 2024-04-16 · $4
  • Consulting for Venclexta · 2024-02-21 · $1,225
BeiGene USANone$133
1 payment
  • Meals · 2024-04-18 · $133
Boston ScientificNone$36
1 payment
  • Meals · 2024-03-18 · $36
Janssen BiotechImbruvica$33
1 payment
  • Meals for Imbruvica · 2024-04-16 · $33
Rigel PharmaceuticalsRezlidhia$29
1 payment
  • Meals for Rezlidhia · 2024-03-05 · $29
AstraZeneca Pharmaceuticals LPCalquence$28
1 payment
  • Meals for Calquence · 2024-11-05 · $28
E.R. Squibb & Sons L.L.C.Opdivo$18
1 payment
  • Meals for Opdivo · 2024-10-29 · $18

2023: $1,686

Payments by company in 2023
Lilly USANone$1,000
1 payment
  • Paid to speak or teach · 2023-12-19 · $1,000
AbbvieVenclexta$455
5 payments
  • Meals for Epkinly · 2023-12-11 · $53
  • Meals for Venclexta · 2023-11-08 · $70
  • Travel for Venclexta · 2023-11-08 · $246
  • Meals for Venclexta · 2023-11-08 · $25
  • Meals for Venclexta · 2023-11-08 · $60
AstraZeneca Pharmaceuticals LPCalquence$141
2 payments
  • Meals for Calquence · 2023-11-10 · $86
  • Meals for Calquence · 2023-05-23 · $55
AtricureAtricure Cryoice Cryoablation System (Cryo2)$38
1 payment
  • Meals for Atricure Cryoice Cryoablation System (Cryo2) · 2023-07-25 · $38
Pharmacyclics LLC An AbbVieImbruvica$27
1 payment
  • Meals for Imbruvica · 2023-03-08 · $27
Novartis PharmaceuticalsPromacta$24
1 payment
  • Meals for Promacta · 2023-05-24 · $24

2022: $1,031

Payments by company in 2022
AstraZeneca Pharmaceuticals LPCalquence$580
1 payment
  • Consulting for Calquence · 2022-06-26 · $580
AbbvieVenclexta$438
1 payment
  • Consulting for Venclexta · 2022-02-17 · $438
Novartis PharmaceuticalsScemblix$13
1 payment
  • Meals for Scemblix · 2022-01-25 · $13

2021: $1,780

Payments by company in 2021
BeiGeneNone$1,040
1 payment
  • Consulting · 2021-06-29 · $1,040
AbbVieVenclexta$740
3 payments
  • Meals for Venclexta · 2021-08-03 · $122
  • Meals for Venclexta · 2021-06-17 · $6
  • Consulting for Venclexta · 2021-06-17 · $613

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1194731034
Licence
CA 55048, MN 10369California A55048: Current · expires 2027-10-31
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
MN 799405000
Taxonomy
Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-07-31
NPI last updated
2025-12-18
NPI record certified
2025-12-18

This is when the NPI record was last certified, not a medical board exam.